About Intero Biosystems
Intero Biosystems is a company based in Ann Arbor (United States) founded in 2024. It operates as a B2B. Intero Biosystems offers products and services including GastroScreen and Organoids. Intero Biosystems operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Vivodyne and Adapsyn, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intero Biosystems
Intero Biosystems offers a comprehensive portfolio of products and services, including GastroScreen and Organoids.
Stem-cell-derived intestinal organoid for preclinical drug testing.
Miniature organ replicas for predictive testing in research.
Funding Insights of Intero Biosystems
Detailed funding history for Intero Biosystems
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intero Biosystems
Investment portfolio details for Intero Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intero Biosystems
Detailed financials for Intero Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intero Biosystems Comparisons
Peer comparison for Intero Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intero Biosystems
Intero Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Vivodyne and Adapsyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| Locked | Locked | Locked |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| Locked | Locked | Locked |
Developer of AI-based platform for lab-grown human tissues
|
|
| Locked | Locked | Locked |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
|
| Locked | Locked | Locked |
Drug safety risks are predicted via AI in pharmaceuticals.
|
Detailed competitors of Intero Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intero Biosystems
Complete news archive for Intero Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intero Biosystems
Intero Biosystems was founded in 2024.
Intero Biosystems is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Intero Biosystems creates stem-cell-derived organoids, such as GastroScreen, to model human organs for drug testing. These miniature structures replicate intestinal functions, allowing researchers to evaluate drug safety and efficacy before clinical trials, thus reducing costs and risks. The company focuses on advancing predictive human models for pharmaceutical applications and is based in the US, serving research and biotech firms.
Intero Biosystems's top competitors include Newcells Biotech, InSphero and Vivodyne.
Intero Biosystems offers GastroScreen and Organoids.